Overproduction of large VLDL particles is driven by increased liver fat content in man

Cited by (690)

Items 101–200 of 690

1. Serum Butyrylcholinesterase is Strongly Associated with Adiposity, the Serum Lipid Profile and Insulin Resistance
   Tomoyuki Iwasaki, Masato Yoneda, Atsushi Nakajima, Yasuo Terauchi · 2007 · Internal Medicine
2. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
   Sattar, N., Wannamethee, S. G., Forouhi, N. G. · 2008 · Diabetologia
3. New insights into the mechanism of low high-density lipoprotein cholesterol in obesity
   Wang, Hao, Peng, Dao-Quan · 2011 · Lipids in Health and Disease
4. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice
   Julia M. Assini, Erin E. Mulvihill, Brian G. Sutherland, Dawn E. Telford, Cynthia G. Sawyez, Sarah L Felder, Sanjiv S. Chhoker, Jane Y. Edwards, Robert Gros, Murray W. Huff · 2012 · Journal of Lipid Research
5. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
   Eeva Sliz, Sylvain P Sebert, Peter Würtz, Antti J. Kangas, Pasi Soininen, Terho J. Lehtimäki, Mika A. P. Kähönen, Jorma S.A. Viikari, Minna Männikkö, Mika Ala‐Korpela et al. · 2018 · Human Molecular Genetics
6. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
   Paola Loria, Giulio Marchesini, Fabio Nascimbeni, Stefano Ballestri, Mauro Maurantonio, Francesca Carubbi, Vlad Ratziu, Amedeo Lonardo · 2013 · Atherosclerosis
7. Adiponectin and lipoprotein metabolism
   Georgios A. Christou, Dimitrios Nikiforos Kiortsis · 2013 · Obesity Reviews
8. FoxO1 integrates insulin signaling to VLDL production.
   Kamagate, Adama, Dong, H. Henry · 2008 · Cell Cycle
9. Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study
   Sattar, Naveed, McConnachie, Alex, Ford, Ian, Gaw, Allan, Cleland, Stephen J., Forouhi, Nita G., McFarlane, Peter, Shepherd, James, Cobbe, Stuart, Packard, Chris · 2007 · Diabetes
10. Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: a single-centre randomized controlled study
    Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan · 2019 · Diabetes, Obesity and Metabolism
11. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
    Packard, Chris J · 2006 · Current Opinion in Lipidology
12. Gut-liver interaction in triglyceride-rich lipoprotein metabolism
    Changting Xiao, Joanne Hsieh, Khosrow Adeli, Gary F. Lewis · 2011 · American Journal of Physiology-Endocrinology and Metabolism
13. Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes
    Rehab M. Elgharabawy, Ashraf M. Emara, Sally El-Sayed Abu-Risha · 2016 · Biomedicine & Pharmacotherapy
14. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
    Musso, Giovanni, Cassader, Maurizio, De Michieli, Franco, Rosina, Floriano, Orlandi, Fabio, Gambino, Roberto · 2012 · Hepatology
15. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.
    Kotronen, A., Seppälä-Lindroos, A., Bergholm, R., Yki-Järvinen, H. · 2007 · Diabetologia
16. Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
    Hannele Yki‐Järvinen · 2010 · Digestive Diseases
17. Relationship between NAFLD and coronary artery disease: A Mendelian randomization study
    Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers · 2022 · Hepatology
18. Drug-induced fatty liver disease: An overview of pathogenesis and management
    Sanjaya Kumar Satapathy, Vanessa K. Kuwajima, Jeffrey Nadelson, Omair Atiq, Arun Jayant Sanyal · 2015 · Annals of Hepatology
19. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study
    Benoît J. Arsenault, Isabelle Lemieux, Jean‐Pierre Després, Pascale Gagnon, Nicholas J. Wareham, Erik S.G. Stroes, John J.P. Kastelein, Kay‐Tee Khaw, S. Matthijs Boekholdt · 2009 · Atherosclerosis
20. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
    Vincenzo Di Marzo, An Verrijken, Antti Hakkarainen, Stefania Petrosino, Ilse L. Mertens, Nina M I Lundbom, Fabiana Piscitelli, Jukka Westerbacka, Aino Soro‐Paavonen, Isabel Matias et al. · 2009 · European Journal of Endocrinology
21. Polymorphism in microsomal triglyceride transfer protein
    Roberto Gambino, Maurizio Cassader, Gianfranco Pagano, Marilena Durazzo, Giovanni Musso · 2007 · Hepatology
22. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD
    Shojaee-Moradie, F., Cuthbertson, D. J., Barrett, M., Jackson, N. C., Herring, R., Thomas, E. L., Bell, J., Kemp, G. J., Wright, J., Umpleby, A. M. · 2016 · The Journal of Clinical Endocrinology & Metabolism
23. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study
    Paolo Salvi, R Ruffini, Davide Agnoletti, Elena Magnani, Gabriele Pagliarani, Giulia Comandini, Antonino Praticò, Claudio Borghi, Athanase Bénétos, P. Pazzi · 2010 · Journal of Hypertension
24. Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders
    Hajime Sasaki, Kimito Hirai, Christine Men Martins, Hisako Furusho, Ricardo A. Battaglino, Koshi Hashimoto · 2016 · Current Pharmaceutical Design
25. Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
    Éric Hajduch, Floriane Lachkar, Pascal Ferré, Fabienne Foufelle · 2021 · Journal of Clinical Medicine
26. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
    Jan Oscarsson, Kristina Önnerhag, Ulf Risérus, Mattias Sundén, Lars Johansson, Per‐Anders Jansson, Linda Moris, Peter M. Nilsson, Jan W. Eriksson, Lars Lind · 2018 · Journal of clinical lipidology
27. Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk
    Birgit Gustafson, Ulf Smith · 2015 · Atherosclerosis
28. Cardiac Steatosis Associates With Visceral Obesity in Nondiabetic Obese Men
    Marit Granér, Reijo Sirén, Kristofer Nyman, Jesper Lundbom, Antti Hakkarainen, Markku O. Pentikäinen, Kirsi Lauerma, Nina M I Lundbom, Martin Adiels, Markku S. Nieminen et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism
29. The genetics of familial combined hyperlipidaemia
    Brouwers, Martijn C. G. J., van Greevenbroek, Marleen M. J., Stehouwer, Coen D. A., de Graaf, Jacqueline, Stalenhoef, Anton F. H. · 2012 · Nature Reviews Endocrinology
30. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
    Jun Inaishi, Yoshifumi Saisho · 2020 · Nutrients
31. VLDL triglyceride kinetics in lean, overweight, and obese men and women
    Mittendorfer, Bettina, Yoshino, Mihoko, Patterson, Bruce W., Klein, Samuel · 2016 · The Journal of Clinical Endocrinology & Metabolism
32. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease
    Abdelbasset, Walid Kamal, Tantawy, Sayed A., Kamel, Dalia M., Alqahtani, Bader A., Soliman, Gaber S. · 2019 · Medicine
33. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
    Jussi Pihlajamäki, Tiina Kuulasmaa, Dorota Kamińska, Marko Simonen, Vesa J. Kärjä, Sari Grönlund, Pirjo Käkelä, Matti E. Pääkkönen, Sakari Kainulainen, Kari R.A. Punnonen et al. · 2011 · Journal of Hepatology
34. Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetes
    Roy Taylor · 2012 · Diabetic Medicine
35. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein
    Johnson, Scott M., Bao, Hanmei, McMahon, Cailin E., Chen, Yongbin, Burr, Stephanie D., Anderson, Aaron M., Madeyski-Bengtson, Katja, Lindén, Daniel, Han, Xianlin, Liu, Jun · 2024 · Nature Communications
36. Non-alcoholic fatty liver disease and cardiovascular risk
    Ángel Brea, José Puzo · 2012 · International Journal of Cardiology
37. The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women
    Leanne Hodson, Alex S. T. Bickerton, Siobhán McQuaid, Rachel Roberts, Fredrik Karpe, Keith N. Frayn, Barbara A. Fielding · 2007 · Diabetes
38. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice
    Wei-Hsuan Hsu, Ting-Hung Chen, Bao‐Hong Lee, Ya-Wen Hsu, Tzu‐Ming Pan · 2013 · Food and Chemical Toxicology
39. Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes
    Marcus Ståhlman, H. T. Pham, Martin Adiels, Todd W. Mitchell, Stephen J. Blanksby, Björn Fagerberg, Kim Ekroos, Jan Borén · 2012 · Diabetologia
40. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study
    Eline H. van den Berg, Lynnda J. N. van Tienhoven‐Wind, Marzyeh Amini, Tim C. M. A. Schreuder, Klaas Nico Faber, Hans Blokzijl, Robin P. F. Dullaart · 2016 · Metabolism
41. NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
    Veerle Bieghs, Patrick C.N. Rensen, Marten H. Hofker, Ronit Shiri‐Sverdlov · 2011 · Atherosclerosis
42. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes
    Bruno L Vergès · 2010 · Atherosclerosis
43. Increased Whole‐Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction
    Faidon Magkos, Elisa Fabbrini, B. Selma Mohammed, Bruce W. Patterson, Samuel Klein · 2010 · Obesity
44. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
    Soo Kyung Lim, Marja‐Riitta Taskinen, Jan Borén · 2018 · Obesity Reviews
45. Di(2-ethylhexyl) phthalate exacerbates non-alcoholic fatty liver in rats and its potential mechanisms
    Hao Chen, Wang Zhang, Bei-bei Rui, Simin Yang, Weiping Xu, Wei Wei · 2015 · Environmental Toxicology and Pharmacology
46. Kinetics of plasma triglycerides in abdominal obesity
    Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Jan Borén · 2016 · Current Opinion in Lipidology
47. Effects of exercise training on intrahepatic lipid content in humans
    Brouwers, Bram, Hesselink, Matthijs K. C., Schrauwen, Patrick, Schrauwen-Hinderling, Vera B. · 2016 · Diabetologia
48. Are Fruit Juices Healthier Than Sugar-Sweetened Beverages? A Review
    Alexandra Pepin, Kimber L. Stanhope, Pascal Imbeault · 2019 · Nutrients
49. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
    William Nseir, Adel Shalata, Alon T Marmor, Nimer Assy · 2011 · Digestive Diseases and Sciences
50. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
    Anna Cabré, Iolanda Lázaro, Josefa Girona, José María Manzanares, Francesc Marimón, Núria Plana, Mercedes Heras, L. Masana · 2008 · Journal of Lipid Research
51. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis
    Ville Männistö, Marko Simonen, Pasi Soininen, Mika Tiainen, Antti J. Kangas, Dorota Kamińska, Sari Venesmaa, Pirjo Käkelä, Vesa J. Kärjä, Helena Gylling et al. · 2014 · Journal of Lipid Research
52. Triglyceride-rich lipoproteins and remnants: targets for therapy?
    Dallinga-Thie, Geesje M., Kroon, Jeffrey, Borén, Jan, Chapman, M. John · 2016 · Current Cardiology Reports
53. Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a
    Robert Bandsma, Berthil H.C.M.T. Prinsen, Monique G.M. de Sain–van der Velden, J. P. Rake, Theo S Boer, Gerrit Smit, Dirk‐Jan Reijngoud, Folkert Kuipers · 2008 · Pediatric Research
54. FT‐IR spectroscopy in diagnosis of diabetes in rat animal model
    Feride Severcan, Ozlem Bozkurt, Rafig Gurbanov, Gúvenç Görgülü · 2010 · Journal of Biophotonics
55. Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
    Björn Eliasson, Diane L. Möller-Goede, Katarina Eeg‐Olofsson, C. Wilson, Jan Cederholm, Penny R. Fleck, Michaëla Diamant, Marja‐Riitta Taskinen, Ulf Smith · 2012 · Diabetologia
56. Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories
    Kimber L. Stanhope, Michael I. Goran, Anja Bosy‐Westphal, Janet C. King, Laura Anne Schmidt, Jean‐Marc Schwarz, Eric M. Stice, Allison Cara Sylvetsky, Peter James Turnbaugh, George A. Bray et al. · 2018 · Obesity Reviews
57. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
    Charlotte Green, Camilla Pramfalk, Catriona A. Charlton, Pippa J. Gunn, Thomas Cornfield, Michael Pavlides, Fredrik Karpe, Leanne Hodson · 2020 · BMJ Open Diabetes Research & Care
58. Hepatic Protection by Noni Fruit Juice Against CCl4-Induced Chronic Liver Damage in Female SD Rats
    Mian-Ying Wang, Gary Anderson, Diane Nowicki, Jarakae C. Jensen · 2008 · Plant Foods for Human Nutrition
59. Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
    Keirns, Bryant H., Sciarrillo, Christina M., Koemel, Nicholas A., Emerson, Sam R. · 2021 · Journal of Nutritional Science
60. Lipoprotein metabolism in nonalcoholic fatty liver disease
    Zhenghui Gordon Jiang, Krzysztof Adam Simon, Yao Zemin · 2013 · Journal of Biomedical Research
61. Metabolic characterization of the natural progression of chronic hepatitis B
    Johannes C. Schoeman, Jun Hou, Amy C. Harms, Rob J. Vreeken, Ruud Berger, Thomas Hankemeier, André Boonstra · 2016 · Genome Medicine
62. Role of folate in nonalcoholic fatty liver disease
    Victoria Sid, Yaw Loong Siow, O Karmin · 2017 · Canadian Journal of Physiology and Pharmacology
63. Postprandial Hypertriglyceridemia and Cardiovascular Disease: Current and Future Therapies
    Dick C. Chan, Jing Pang, G. Romic, Gerald Francis Watts · 2013 · Current Atherosclerosis Reports
64. Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?
    Martijn C.G.J. Brouwers, Chantal Jacobs, Aalt Bast, Coen D.A. Stehouwer, Nicolaas C. Schaper · 2015 · Trends in Molecular Medicine
65. A Role for Hepatic Leptin Signaling in Lipid Metabolism via Altered Very Low Density Lipoprotein Composition and Liver Lipase Activity in Mice
    Frank K. Huynh, Ursula H. Neumann, Ying Wang, Brian B. Rodrigues, Timothy J. Kieffer, Scott D. Covey · 2012 · Hepatology
66. Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study
    Carlos Lorenzo, S. Dyer Hartnett, Anthony J. Hanley, Marian Rewers, Lynne E. Wagenknecht, Andrew John Karter, Steven M. Haffner · 2013 · The Journal of Clinical Endocrinology & Metabolism
67. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet
    Gisella Mutungi, David D. Waters, Joseph C. Ratliff, Michael J. Puglisi, Richard M. Clark, Jeff S. Volek, María Luz Fernández · 2009 · The Journal of Nutritional Biochemistry
68. Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
    Yun‐Jung Choi, Brian K. Roberts, Xueyan Wang, J. Casey Geaney, Sue Naim, Kathleen Wojnoonski, David B. Karpf, Ronald M. Krauss · 2011 · Atherosclerosis
69. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats
    Xabier Buqué, María José Martínez, Ainara Cano, María E. Miquilena-Colina, Carmelo García‐Monzón, Patricia Aspichueta, Begoña Ochoa · 2009 · Journal of Lipid Research
70. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH
    Manoj Amrutkar, Emmelie Cansby, Esther Nuñez‐Durán, Carlo Pirazzi, Marcus Ståhlman, Elin Stenfeldt, Ulf Smith, Jan Borén, Margit Mahlapuu · 2015 · The FASEB Journal
71. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
    Borén, Jan, Adiels, Martin, Björnson, Elias, Matikainen, Niina, Söderlund, Sanni, Rämö, Joel, Ståhlman, Marcus, Ripatti, Pietari, Ripatti, Samuli, Palotie, Aarno et al. · 2020 · JCI Insight
72. Paradoxical Dissociation Between Hepatic Fat Content and De Novo Lipogenesis Due to PNPLA3 Sequence Variant
    Rosellina Margherita Mancina, Niina Matikainen, Cristina Maglio, Sanni Söderlund, Nina M I Lundbom, Antti Hakkarainen, Raffaela Rametta, Enrico Mozzi, Silvia Rossana Fargion, Luca V. C. Valenti et al. · 2015 · The Journal of Clinical Endocrinology & Metabolism
73. Acute high-intensity endurance exercise is more effective than moderate-intensity exercise for attenuation of postprandial triglyceride elevation
    Justin R. Trombold, Kevin M. Christmas, Daniel R. Machin, Il-Young Kim, Edward F. Coyle · 2013 · Journal of Applied Physiology
74. Postprandial Lipemia Associates with Liver Fat Content
    Niina Matikainen, S. Mänttäri, Jukka Westerbacka, Satu Vehkavaara, Nina M I Lundbom, Hannele Yki‐Järvinen, Marja‐Riitta Taskinen · 2007 · The Journal of Clinical Endocrinology & Metabolism
75. Hepatic fatty acid partitioning
    Leanne Hodson, Keith N. Frayn · 2011 · Current Opinion in Lipidology
76. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study
    Martijn C.G.J. Brouwers, Jason S. Troutt, Marleen M. J. van Greevenbroek, Isabel Ferreira, Edith J. M. Feskens, Carla Kallen, Nicolaas C. Schaper, Caspar Schalkwijk, Robert J. Konrad, Coen D.A. Stehouwer · 2011 · Atherosclerosis
77. Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
    Mireille A. Edens, Folkert Kuipers, Ronald P. Stolk · 2009 · Obesity Reviews
78. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts
    Anna Kotronen, Hannele Yki‐Järvinen, Anna Aminoff, Robert Bergholm, Kirsi Hannele Pietiläinen, Jukka Westerbacka, Philippa J. Talmud, Steve Eric Humphries, Anders Hamsten, Bo Isomaa et al. · 2009 · European Journal of Endocrinology
79. Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men
    Marinou, Kyriakoula, Adiels, Martin, Hodson, Leanne, Frayn, Keith N., Karpe, Fredrik, Fielding, Barbara A. · 2011 · British Journal Of Nutrition
80. Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women
    Leanne Hodson, Rajarshi Banerjee, Belén Rial, Wiebke Arlt, Martin Adiels, Jan Borén, Kyriakoula Marinou, Ciarán Fisher, Ingrid Løvold Mostad, IRENE M. STRATTON et al. · 2015 · Journal of the American Heart Association
81. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study
    Borén, Jan, Watts, Gerald F., Adiels, Martin, Söderlund, Sanni, Chan, Dick C., Hakkarainen, Antti, Lundbom, Jesper, Lundbom, Nina, Matikainen, Niina, Kahri, Juhani et al. · 2015 · Arteriosclerosis, Thrombosis, and Vascular Biology
82. Long-Lasting Improvements in Liver Fat and Metabolism Despite Body Weight Regain After Dietary Weight Loss
    Sven Haufe, Verena K. Haas, Wolfgang Utz, Andreas L. Birkenfeld, Stephanie Jeran, Jana Böhnke, Anja Mähler, Friedrich Cameron Luft, Jeanette Schulz‐Menger, Michael Boschmann et al. · 2013 · Diabetes Care
83. Effects of bariatric surgery on lipid-lipoprotein profile
    Marie‐Ève Piché, Isabelle Tardif, Audrey Auclair, Paul Poirier · 2020 · Metabolism
84. Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik Study
    Lauren J. Kim, Mike A. Nalls, Guðný Eiríksdóttir, Sigurdur Oli Sigurdsson, Lenore J. Launer, Annemarie Koster, Paulo H. M. Chaves, Birna Jónsdóttir, Melissa García, Vilmundur G. Gudnason et al. · 2010 · Obesity
85. Abdominal obesity and circulating metabolites: A twin study approach
    Leonie Helen Bogl, Sanna M. Kaye, Joel T Rämö, Antti J. Kangas, Pasi Soininen, Antti Hakkarainen, Jesper Lundbom, Nina M I Lundbom, Alfredo Ortega‐Alonso, Aila Rissanen et al. · 2015 · Metabolism
86. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity
    Martin Adiels, Niina Matikainen, Jukka Westerbacka, Sanni Söderlund, Thomas P. Larsson, Sven‐Olof Olofsson, Jan Borén, Marja‐Riitta Taskinen · 2012 · Atherosclerosis
87. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?
    Leanne Hodson, Siobhán McQuaid, Sandy M. Humphreys, Ross W. Milne, Barbara A. Fielding, Keith N. Frayn, Fredrik Karpe · 2010 · American Journal of Physiology-Endocrinology and Metabolism
88. Ginsenoside Re Ameliorates Brain Insulin Resistance and Cognitive Dysfunction in High Fat Diet-Induced C57BL/6 Mice
    Jong Min Kim, Chang Hyeon Park, Seon Kyeong Park, Tae Wan Seung, Jin Yong Kang, Jeong Su Ha, Du Sang Lee, Uk Lee, Dae‐Ok Kim, Ho Jin Heo · 2017 · Journal of Agricultural and Food Chemistry
89. Inherited lipodystrophies and hypertriglyceridemia.
    Simha, Vinaya, Garg, Abhimanyu · 2009 · Current Opinion in Lipidology
90. The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.
    Elias E. Mazokopakis, Maria G. Papadomanolaki, Andreas A Fousteris, Dimitrios A Kotsiris, Ioannis Lampadakis, Emmanuel S. Ganotakis · 2014 · Europe PMC (PubMed Central)
91. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia
    Martijn C.G.J. Brouwers, Rita M. Cantor, Naoko Kono, Jeong lim Yoon, Carla Kallen, Monique A. L. Bilderbeek-Beckers, Marleen M. J. van Greevenbroek, Aldons Jake Lusis, Tjerk WA de Bruin · 2006 · Journal of Lipid Research
92. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
    Martínez‐Arranz, Ibon, Bruzzone, Chiara, Noureddin, Mazen, Gil‐Redondo, Ruben, Mincholé, Itziar, Bizkarguenaga, Maider, Arretxe, Enara, Iruarrizaga‐Lejarreta, Marta, Fernández‐Ramos, David, Lopitz‐Otsoa, Fernando et al. · 2022 · Hepatology
93. Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies
    William Nseir, Julnar Mograbi, Murad Ghali · 2012 · Digestive Diseases and Sciences
94. Comparison of the Relative Contributions of Intra‐Abdominal and Liver Fat to Components of the Metabolic Syndrome
    Anna Kotronen, Hannele Yki‐Järvinen, Ksenia Sevastianova, Robert Bergholm, Antti Hakkarainen, Kirsi Hannele Pietiläinen, Leena Juurinen, Nina M I Lundbom, Thorkild I.A. Sørensen · 2010 · Obesity
95. Tumor necrosis factor-α directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling
    Bolin Qin, Richard A. Anderson, Khosrow Adeli · 2008 · American Journal of Physiology-Gastrointestinal and Liver Physiology
96. Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders
    Lynnda J. N. van Tienhoven‐Wind, Robin P. F. Dullaart · 2015 · European Journal of Clinical Investigation
97. Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
    Shilpa R. Nagarajan, Eloise Cross, Fabio Sanna, Leanne Hodson · 2021 · Proceedings of The Nutrition Society
98. Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
    Michael Allison, Julian Leether Griffin, Michèle Vacca, Antonio Vidal‐Puig · 2015 · Seminars in Liver Disease
99. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
    Leanne Hodson, Lokpal S. Bhatia, Eleonora Scorletti, Debbie E. Smith, N C Jackson, Fariba Shojaee‐Moradie, Anne Margot Umpleby, Philip C. Calder, Christopher D. Byrne · 2017 · European Journal of Clinical Nutrition
100. Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion
     Ebe D’Adamo, Veronika S. Northrup, Ram Weiss, Nicola Santoro, Bridget M. Pierpont, Mary Savoye, Grace O’Malley, Sonia Caprio · 2010 · American Journal of Clinical Nutrition